Search
for
Sort by
Research 631–660 of 1000+
- Hormone Therapy in the Era of the COVID-19 Pandemic: A Review
- Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies
- Sociodemographic predictors of outcomes in COVID-19: examining the impact of ethnic disparities in Northern Nevada
- Transitional Changes in Fatigue-Related Symptoms Due to Long COVID: A Single-Center Retrospective Observational Study in Japan
- Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
- “MATH+” Multi-Modal Hospital Treatment Protocol for COVID-19 Infection: Clinical and Scientific Rationale
- Polymorphism of genes in patients with new coronavirus infection COVID-19
- Sociodemographic Predictors of Outcomes in COVID-19: Examining the Impact of Ethnic Disparities in Northern Nevada
- New insights into alopecia areata during COVID‐19 pandemic: When infection or vaccination could play a role
- The Silent Syndrome of Long COVID and Gaps in Scientific Knowledge: A Narrative Review
- Consumer attitudes toward aging skin during the COVID-19 pandemic
- ACE1 rs1799752 polymorphism is not associated with long-COVID symptomatology in previously hospitalized COVID-19 survivors
- Role of ACE2 polymorphism in COVID-19: impact of age
- The Pathological Culprit of Neuropathic Skin Pain in Long COVID-19 Patients: A Case Series
- Hair and nail manifestations of COVID‐19
- Contrasting Narratives of Race and Fatness in Covid-19
- Proxalutamide Improves Inflammatory, Immunologic, and Thrombogenic Markers in Mild-to-Moderate COVID-19 Males and Females: an Exploratory Analysis of a Randomized, Double-Blinded, Placebo-Controlled Trial Early Antiandrogen Therapy (EAT) with Proxalutamide (The EAT-Proxa Biochemical AndroCoV-Trial)
- Proxalutamide Reduction of Mortality Rate in Hospitalized COVID-19 Patients Depends on Treatment Duration – an Exploratory Analysis of the Proxa-Rescue AndroCoV Trial
- Clinical course of alopecia after COVID-19
- Association between Mesenchymal Stem Cells and COVID-19 Therapy: Systematic Review and Current Trends
- Androgenetic alopecia in women and men is not related to COVID‐19 infection severity: a prospective cohort study of hospitalized COVID‐19 patients
- Gender/sex, race/ethnicity, similarities/differences among SARS-CoV, MERS-CoV, and COVID-19 patients
- Analysing the patient experience of COVID‐19: Exploring patients' experiences of hospitalisation and their quality of life post discharge
- New‐onset and exacerbated skin diseases after COVID‐19 infection: A systematic review
- Correlation Between Nongenomic Action of C19-Steroids and COVID-19 Severity
- Androgens and Antiandrogens influence on COVID-19 disease in men
- Autoimmune Skin Diseases in the Era of COVID-19: Pathophysiological Insights and Clinical Implications
- A window into the vascular endothelium in COVID-19: Nails
- Association of ACE2, Insulin Resistance, and Other Parameters in Obese Polycystic Ovary Syndrome Patients Infected with COVID-19
- Extrapulmonary manifestations of coronavirus disease (COVID-19): current status (a literature review)